UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.1753-1765

2019

Volltextzugriff (PDF)

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation

Journal of hematology and oncology, 2022-06, Vol.15 (1), p.79-79, Article 79

2022

Volltextzugriff (PDF)

EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib

Journal of thoracic oncology, 2018-05, Vol.13 (5), p.727-731

2018

Volltextzugriff (PDF)

Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers-Applications and Limitations

Cells (Basel, Switzerland), 2021-02, Vol.10 (2), p.354

2021

Volltextzugriff (PDF)

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study

Translational lung cancer research, 2020-10, Vol.9 (5), p.1915-1923

2020

Volltextzugriff (PDF)

Prognostic value of plasma fibrinogen and d-dimer levels in patients with surgically resected non-small cell lung cancer

Surgery today (Tokyo, Japan), 2020-11, Vol.50 (11), p.1427-1433

2020

Volltextzugriff (PDF)

The prevalence and risk factors associated with preoperative deep venous thrombosis in lung cancer surgery

Surgery today (Tokyo, Japan), 2021-09, Vol.51 (9), p.1480-1487

2021

Volltextzugriff (PDF)

Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms—An In Vitro Study

Biomedicines, 2024-06, Vol.12 (7), p.1412

2024

Volltextzugriff (PDF)

Life-threatening complications after pulmonary resection for lung cancer in patients on chronic hemodialysis

Surgery today (Tokyo, Japan), 2019-06, Vol.49 (6), p.513-520

2019

Volltextzugriff (PDF)

Activity of tarloxotinib‐E in cells with EGFR exon‐20 insertion mutations and mechanisms of acquired resistance

Thoracic cancer, 2021-05, Vol.12 (10), p.1511-1516

2021

Volltextzugriff (PDF)

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC

JTO clinical and research reports, 2022-05, Vol.3 (5), p.100321-100321, Article 100321

2022

Volltextzugriff (PDF)

Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study

Translational lung cancer research, 2021-08, Vol.10 (8), p.3659-3670

2021

Volltextzugriff (PDF)

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing

JTO clinical and research reports, 2023-09, Vol.4 (9), p.100554-100554, Article 100554

2023

Volltextzugriff (PDF)

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study

Translational lung cancer research, 2020-10, Vol.9 (5), p.1915-1923

2020

Volltextzugriff (PDF)

Primary pulmonary mucosa-associated lymphoid tissue lymphoma with amyloid light chain-type amyloidosis

Surgical case reports, 2019-06, Vol.5 (1), p.105-4, Article 105

2019

Volltextzugriff (PDF)

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments

Journal of thoracic oncology, 2021-08, Vol.16 (8), p.1321-1332

2021

Volltextzugriff (PDF)

Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion

Journal of thoracic oncology, 2024-01, Vol.19 (1), p.71-79

2024

Volltextzugriff (PDF)

Metastatic pulmonary tumor from type 3 gastric neuroendocrine tumor

Human pathology : case reports, 2021-03, Vol.23, p.200481, Article 200481

2021

Volltextzugriff (PDF)

A case of multiple endocrine neoplasia (MEN) type 1 detected from thymus carcinoid

The Journal of the Japanese Association for Chest Surgery, 2020/03/15, Vol.34(2), pp.121-125

2020

Volltextzugriff (PDF)

IS9-1. Surgical risks and long-term outcomes of lobectomy in NSCLC patients with autoimmune diseases

Japanese Journal of Lung Cancer, 2019-11, Vol.59 (6), p.639-639

2019

Volltextzugriff (PDF)

IS3-2. Inter- and intra-tumor heterogeneity of EGFR compound mutations in lung adenocarcinoma

Japanese Journal of Lung Cancer, 2020-10, Vol.60 (6), p.523-523

2020

Volltextzugriff (PDF)

IS9-5. pStage IA NSCLCs with GGO : are they candidates for Tegafur / Uracil adjuvant chemotherapy?

Japanese Journal of Lung Cancer, 2019-11, Vol.59 (6), p.641-641

2019

Volltextzugriff (PDF)

A case of lung cancer associated with remitting seronegative symmetrical synovitis with pitting edema syndrome

The Journal of the Japanese Association for Chest Surgery, 2018/03/15, Vol.32(2), pp.136-140

2018

Volltextzugriff (PDF)

A case of lung cancer associated with remitting seronegative symmetrical synovitis with pitting edema syndrome

Nihon Kokyuki Geka Gakkai zasshi (Kyoto, 1992), 2018, Vol.32 (2), p.136-140

2018

Volltextzugriff (PDF)

胸腺カルチノイドを契機として発見された多発性内分泌腫瘍（MEN）1型の1症例

日本呼吸器外科学会雑誌, 2020/03/15, Vol.34(2), pp.121-125

2020

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(42)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro

Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutation

EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib

Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers-Applications and Limitations

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study

Prognostic value of plasma fibrinogen and d-dimer levels in patients with surgically resected non-small cell lung cancer

The prevalence and risk factors associated with preoperative deep venous thrombosis in lung cancer surgery

Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms—An In Vitro Study

Life-threatening complications after pulmonary resection for lung cancer in patients on chronic hemodialysis

Activity of tarloxotinib‐E in cells with EGFR exon‐20 insertion mutations and mechanisms of acquired resistance

Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC

Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study

Primary pulmonary mucosa-associated lymphoid tissue lymphoma with amyloid light chain-type amyloidosis

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments

Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion

Metastatic pulmonary tumor from type 3 gastric neuroendocrine tumor

A case of multiple endocrine neoplasia (MEN) type 1 detected from thymus carcinoid

IS9-1. Surgical risks and long-term outcomes of lobectomy in NSCLC patients with autoimmune diseases

IS3-2. Inter- and intra-tumor heterogeneity of EGFR compound mutations in lung adenocarcinoma

IS9-5. pStage IA NSCLCs with GGO : are they candidates for Tegafur / Uracil adjuvant chemotherapy?

A case of lung cancer associated with remitting seronegative symmetrical synovitis with pitting edema syndrome

A case of lung cancer associated with remitting seronegative symmetrical synovitis with pitting edema syndrome

胸腺カルチノイドを契機として発見された多発性内分泌腫瘍（MEN）1型の1症例

Aktive Filter

Suchergebnisse filtern